There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Structure of Narciclasine
CAS No.: 29477-83-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Narciclasine is a plant growth modulator. Narciclasine modulates the Rho/Rho kinase/LIM kinase/cofilin signaling pathway, greatly increasing GTPase RhoA activity as well as inducing actin stress fiber formation in a RhoA-dependent manner.
Synonyms: Lycoricidinol; (+)-Narciclasine; NSC 266535
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 29477-83-6 |
Formula : | C14H13NO7 |
M.W : | 307.26 |
SMILES Code : | O=C1N[C@@]2([H])[C@H](O)[C@H](O)[C@@H](O)C=C2C3=C1C(O)=C4C(OCO4)=C3 |
Synonyms : |
Lycoricidinol; (+)-Narciclasine; NSC 266535
|
MDL No. : | MFCD01729949 |
GHS Pictogram: |
![]() |
Signal Word: | Danger |
Hazard Statements: | H301 |
Precautionary Statements: | P264-P270-P301+P310-P321-P330-P405-P501 |
Class: | 6.1 |
UN#: | 2811 |
Packing Group: | Ⅲ |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
HT-29 | 0.032 μM (IC50) | 72 hours | Inhibited cell proliferation with IC50 of 0.032 μM | PMC9496155 |
LoVo | 0.023 μM (IC50) | 72 hours | Inhibited cell proliferation with IC50 of 0.023 μM | PMC9496155 |
HCT-116 | 0.052 μM (IC50) | 72 hours | Inhibited cell proliferation with IC50 of 0.052 μM | PMC9496155 |
Yeast strain SAN006 | 0.1 mM | Assess cytotoxicity of sanguinarine | PMC11282404 | |
Ccd-25-Lu normal lung fibroblasts | 1 μM | 18 hours | No marked apoptotic morphological changes induced | PMC1993861 |
PC-3 prostate cancer cells | 1 μM | 18 hours | Induced marked apoptotic morphological changes and loss of mitochondrial membrane potential | PMC1993861 |
MCF-7 breast cancer cells | 1 μM | 18 hours | Induced marked apoptotic morphological changes and loss of mitochondrial membrane potential | PMC1993861 |
Tobacco BY-2 cells | 0.5 and 5.0 μM | 2 days | To study the effects of NCS on cell cycle progression, results showed that NCS inhibits cell division and affects the expression of cell cycle genes. | PMC3282671 |
HCC-1937 | 50 nM | 24 h | To evaluate the inhibitory effect of Narciclasine on HCC-1937 cell proliferation and its ability to induce autophagy-dependent apoptosis | PMC6528917 |
MDA-MB-231 breast cancer cells | 1 μM | 24 hours | Induced DNA laddering | PMC1993861 |
MCF-7/TR cells | 100 nM | 24 hours | Specifically degraded total STAT3 via the proteasome pathway | PMC8783118 |
MCF-7 cells | 100 nM | 24 hours | Suppressed phosphorylation, activation, dimerization, and nuclear translocation of STAT3 | PMC8783118 |
IMG cells | 50 nM | 24 hours | To evaluate the effect of Narciclasine on LPS-induced inflammatory response. Results showed that Narciclasine alone did not induce inflammatory response but exacerbated inflammation when combined with LPS. | PMC10216802 |
BSC-1 cells | 40-320 nM | 24 hours | To evaluate the inhibitory effect of Narciclasine on VACV viral protein expression in BSC-1 cells, showing a dose-dependent decrease in viral protein levels. | PMC11894989 |
Huh7.5.1 cells | 40-320 nM | 24 hours | To evaluate the cytotoxicity of Narciclasine on Huh7.5.1 cells, showing a slight reduction in cell viability starting from 80 nM. | PMC11894989 |
36C15Q cells | 20 nM | 48 hours | Promotes oxidative metabolism gene expression, reduces lipid accumulation | PMC5331945 |
C2C12 cells | 20 nM | 48 hours | Promotes oxidative metabolism gene expression, reduces lipid accumulation | PMC5331945 |
CoN | 1.1 μM (IC50) | 72 hours | Inhibited cell proliferation with IC50 of 1.1 μM | PMC9496155 |
DLD-1 | 0.030 μM (IC50) | 72 hours | Inhibited cell proliferation with IC50 of 0.030 μM | PMC9496155 |
HeLa cells | 40-320 nM | 24 hours | To evaluate the cytotoxicity of Narciclasine on HeLa cells, showing no significant effect on cell viability at ≤320 nM. | PMC11894989 |
Arabidopsis root tip cells | 0.5 and 5.0 μM | 6 to 48 hours | To analyze the effects of NCS on the expression of core cell cycle genes, results showed that NCS disturbs the expression of G1/S and G2/M phase genes. | PMC3282671 |
Neonatal rat cardiomyocytes (NRCMs) | 0, 30, 100, and 300 nM | To evaluate the effect of Narciclasine on LPS-induced inflammation in cardiomyocytes. Results showed that Narciclasine attenuated LPS-induced decrease in cell viability in a dose-dependent manner, suppressed inflammatory cytokine (TNF-α, IL-1β, and IL-6) release, and reduced apoptosis. | PMC8221305 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Mice | High-fat diet-induced obesity model | Oral gavage | 1 mg/kg | Weekly for seven consecutive weeks | Attenuates obesity, promotes energy expenditure, improves metabolic parameters | PMC5331945 |
BALB/c-nu mice | MCF-7 xenograft model | Intraperitoneal injection | 1 mg/kg | Every 2 days for 4 weeks | Significantly reduced tumor size and weight, decreased STAT3 phosphorylation levels | PMC8783118 |
BALB/c nude mice | HCC1937 TNBC xenograft model | Oral | 2 or 5 mg/kg | Three times per week for 21 days | To evaluate the inhibitory effect of Narciclasine on HCC1937 TNBC xenograft tumor growth and its mechanism | PMC6528917 |
BALB/C mice | IMQ-induced psoriasis-like dermatitis model | Intradermal injection | 2mg/kg | Once daily for 6 days | To evaluate the therapeutic effect of Ncs on IMQ-induced psoriasis-like dermatitis, results showed that Ncs significantly improved skin lesions, reduced epidermal thickening and immune cell infiltration. | PMC9869703 |
Arabidopsis | Arabidopsis seedlings | Medium treatment | 0.1, 0.5, 1.0 and 5.0 μM | Continuous treatment for 7 days | To study the inhibitory effects of NCS on Arabidopsis root growth, results showed that NCS significantly inhibited root growth and lateral root density. | PMC3282671 |
C57BL/6 mice | LPS-induced acute myocardial injury model | Gavage | 0.1 mg/kg | Once daily for 7 days | To investigate the protective effect of Narciclasine on LPS-induced myocardial injury. Results showed that Narciclasine partly improved cardiac function parameters (e.g., LVEF and LVFS), increased survival rates, and reduced inflammatory indicators (e.g., MPO and cytokines IL-6, IL-1β, TNF-α, VEGF). | PMC8221305 |
Sprague-Dawley rats | LPS-induced neonatal acute lung injury model | Subcutaneous injection | 0.7 mg/kg | Administered 12 hours prior to LPS exposure, lasting for 72 hours | Narciclasine attenuated LPS-induced pathological injury and pulmonary edema, suppressed the secretion of inflammatory cytokines, alleviated oxidative stress and apoptosis, and exerted protective effects by inhibiting the activation of the TLR4/NF-κB/Cox2 signaling pathway. | PMC8291818 |
Neonatal rats | E. coli-induced sepsis model | Intraperitoneal injection | 0.1 mg/kg, 1 mg/kg, 3 mg/kg | Administered 1 hour after sepsis induction, observed for 30 hours | Narciclasine significantly reduced mortality in neonatal rats with sepsis, alleviated clinical sepsis symptoms, reduced bacterial load, decreased levels of inflammatory cytokines, inhibited the expression of S100A8/A9, alleviated inflammation and injury in liver and lungs, improved hematological parameters, and suppressed the activation of the NF-κB signaling pathway. | PMC7031385 |
Tags: Narciclasine | Lycoricidinol | ROCK | Rho-associated protein kinase | Rho-associated kinase | Rho-kinase | ROK | Alkaloid | Tubulin polymerization inhibitor | Microtubule dynamics | Cancer cells | RhoA activation | Actin stress fibers | Rho kinase pathway | Plant growth modulator | 29477-83-6
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL